title: [Influence of cancer chemotherapy on conjunctival epithelium and goblet cells].
abstract: OBJECTIVE
  Evaluation of different types of chemotherapy schemes administered in lung, breast and bowel cancer on conjunctival epithelium and goblet cells morphology.
  
  
  METHODS
  36 patients (72 eyes) were enrolled to the study. Patients were divided into three groups depending on type of cancer and chemotherapy: group I - patients diagnosed with non- small cells lung cancer treated with PE schema (cisplatin, etoposide), group II - with breast cancer treated with FAC schema (fluorouracil, doxorubicin, cyclophosphamide), group Ill - bowel cancer treated with FU/LV schema (fluorouracil, leucovorin). Examinations were performed before chemotherapy and after Il'th, IV'th, VI'th chemotherapy cycle. Conjuntival specimen were obtained with exfoliative cytology, stained with PAS and hematoxyline.
  
  
  RESULTS
  Statistically significant deterioration of conjunctival epithelium and goblet cells in all the groups in each time of examination (p<0.001) was observed. Alterations were aggravated with duration of chemotherapy. Before chemotherapy all the patients had normal epithelium and goblet cells (grade 0 or 1 according to the Nelson's scale). Conjunctival cells status gradually deteriorated and altered from the normal glandular epithelium to the squamous cells epithelium through the process of squamous metaplasia. In further chemotherapy cycles each patient (1,0 fraction) had abnormal morphology of epithelium and goblet cells (grade 2 or 3 of Nelson's scale).
  
  
  CONCLUSIONS
  Chemotherapy induces squamous metaplasia of epithelium and the reduction of number of conjunctival goblet cells. This abnormalities were time dependent and increased with duration of chemotherapy and were not depended on type of chemotherapy scheme.
authors.affiliation: Klinika Okulistyki i Rehabilitacji Wzrokowej Uniwersytetu Medycznego w todzi Kierownik. kasia2w@poczta.onet.pl
authors.forename: Katarzyna
authors.initials: K
authors.lastname: Wojciechowska
authors.forename: Dorota
authors.initials: D
authors.lastname: Jesionek-Kupnicka
authors.forename: Piotr
authors.initials: P
authors.lastname: Jurowski
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy; D003110:Colonic Neoplasms / Q000188:drug therapy; D003228:Conjunctiva / Q000187:drug effects*; D003229:Conjunctival Diseases / Q000139:chemically induced*; D004847:Epithelial Cells / Q000187:drug effects*; D005260:Female; D020397:Goblet Cells / Q000187:drug effects*; D006801:Humans; D008297:Male; D008679:Metaplasia / Q000139:chemically induced; D008875:Middle Aged; D012307:Risk Factors
chemical_list: D000970:Antineoplastic Agents